News Focus
News Focus
icon url

WideEyed

10/03/25 11:11 PM

#791044 RE: exwannabe #790984

Not talking about “marketing” a combo. NWBO is combining DCVax-L + poly-iclc + PD-1 for off label use as we speak for IFR cancer indications in the UK. Trials are fine and will be unaffected. Nice try Ex. Are you the chief deceiver in charge?